Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROKIDNEY CORP. Director's Dealing 2022

Jul 14, 2022

32485_dirs_2022-07-13_8184e1d8-1090-4f6d-92c2-5e628b8e1212.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2022-07-11

Reporting Person: Sinha Uma (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-07-11 Class A Ordinary Shares A 30000 Acquired 30000 Direct

Footnotes

F1: Represents a grant of 30,000 restricted stock units that vested in full on July 11, 2022 and will settle in Class A Ordinary Shares on a date selected by the issuer between the vesting date and March 15, 2023.